Eribulin Mesylate
NDC 68001-656, Eribulin Mesylate, solution, from BluePoint Laboratories.
- Product NDC
- 68001-656
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214850
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-656 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERIBULIN MESYLATE.5 mg/mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-656-41 | 68001065641 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-656-41) / 2 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a1a9cff-d5da-4232-b98f-26f55208dfc4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-656
Use it
Look up 68001-656 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-656 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-656. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.